{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:55:44Z","timestamp":1793451344322,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Assessing the survival benefit of transplantation in patients with end-stage liver disease is critical in guiding the decision-making process for liver allocation. Previous studies established increased mortality risk for those transplanted below Model for End-Stage Liver Disease (MELD) 18 compared with candidates who remained on the waitlist; however, improved outcomes of liver transplantation and a changing landscape in the donor supply warrant re-evaluation of this idea.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Using the United Network for Organ Sharing database, we analyzed 160\u2009290 candidates who were waitlisted for liver transplantation within MELD cohorts. We compared patients who were transplanted in a MELD cohort with those listed but not transplanted in that listed MELD cohort with an intent-to-treat analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Those transplanted at a MELD between 6 and 11 showed a 31% reduction in adjusted mortality (HR = 0.69 [95% confidence interval [CI], 0.66-0.75]; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) compared with the intent-to-treat cohort in a Cox multivariate regression. This mortality benefit increased to a 37% adjusted reduction for those transplanted at MELD between 12 and 14 (HR = 0.63 [95% CI, 0.60-0.66]; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and a 46% adjusted reduction for those transplanted at a MELD between 15 and 17 (HR = 0.54 [95% CI, 0.52-0.57]; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), effects that remained in sensitivity analyses excluding patients with hepatocellular carcinoma, encephalopathy, ascites, and variceal bleeds. A multivariate analysis of patients transplanted at MELD &lt; 18 found younger age and cold ischemia time were protective, whereas older age, lower functional status, and socioeconomic factors increased mortality risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>These findings challenge the current practice of deferring liver transplants below a particular MELD score by demonstrating survival benefits for most transplant patients at the lowest MELD scores and providing insight into who benefits within these subgroups.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004345","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T19:00:35Z","timestamp":1668193235000},"page":"680-692","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Is Liver Transplant Justified at Any MELD Score?"],"prefix":"10.1097","volume":"107","author":[{"given":"Hannah","family":"Oden-Brunson","sequence":"first","affiliation":[{"name":"Department of Student Affairs, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm F.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Medical Scientist Training Program, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Godfrey","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale School of Medicine, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"Keeling","sequence":"additional","affiliation":[{"name":"Department of Student Affairs, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Cholankeril","sequence":"additional","affiliation":[{"name":"Division of Abdominal Transplant, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX."},{"name":"Section of Gastroenterology and Hepatology, Margaret M and Albert B Alkek Department of Medicine, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fasiha","family":"Kanwal","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology and Hepatology, Margaret M and Albert B Alkek Department of Medicine, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"O\u2019Mahony","sequence":"additional","affiliation":[{"name":"Division of Abdominal Transplant, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Goss","sequence":"additional","affiliation":[{"name":"Division of Abdominal Transplant, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Rana","sequence":"additional","affiliation":[{"name":"Division of Abdominal Transplant, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ajt.15276","article-title":"OPTN\/SRTR 2017 annual data report: liver.","volume":"19","author":"Kim","year":"2019","journal-title":"Am J Transplant"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers.","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jhep.2010.11.008","article-title":"The MELD score in patients awaiting liver transplant: strengths and weaknesses.","volume":"54","author":"Bernardi","year":"2011","journal-title":"J Hepatol"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1111\/ajt.14414","article-title":"Death with low MELD scores and possible implications for organ allocation.","volume":"17","author":"O\u2019Grady","year":"2017","journal-title":"Am J Transplant"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1002\/lt.20265","article-title":"When is a patient too well and when is a patient too sick for a liver transplant?","volume":"10","author":"Merion","year":"2004","journal-title":"Liver Transpl"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","article-title":"The survival benefit of liver transplantation.","volume":"5","author":"Merion","year":"2005","journal-title":"Am J Transplant"},{"key":"R8-20250604","first-page":"166","article-title":"Current status of liver allocation in the United States.","volume":"12","author":"Elwir","year":"2016","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/lt.21703","article-title":"Should liver transplantation in patients with model for end-stage liver disease scores \u2264 14 be avoided? A decision analysis approach.","volume":"15","author":"Perkins","year":"2009","journal-title":"Liver Transpl"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/lt.24307","article-title":"Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.","volume":"21","author":"Kwong","year":"2015","journal-title":"Liver Transpl"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/TP.0000000000002997","article-title":"Patients with persistently low MELD-Na scores continue to be at risk of liver-related death.","volume":"104","author":"Mazumder","year":"2020","journal-title":"Transplantation"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/ajt.14660","article-title":"MELD as a metric for survival benefit of liver transplantation.","volume":"18","author":"Luo","year":"2018","journal-title":"Am J Transplant"},{"key":"R13-20250604","first-page":"84","article-title":"Factors associated with waiting time on the liver transplant list: an analysis of the United Network for Organ Sharing (UNOS) database.","volume":"31","author":"Trieu","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamasurg.2013.4823","article-title":"Morphometric age and mortality after liver transplant.","volume":"149","author":"Waits","year":"2014","journal-title":"JAMA Surg"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"e2468","DOI":"10.1371\/journal.pone.0002468","article-title":"Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis.","volume":"3","author":"Stahl","year":"2008","journal-title":"PLoS One"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/tri.13968","article-title":"Elevated serum sodium in recipients of liver transplantation has a substantial impact on outcomes.","volume":"34","author":"McDonald","year":"2021","journal-title":"Transpl Int"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases.","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/TP.0000000000002523","article-title":"Ethnic and age disparities in outcomes among liver transplant waitlist candidates.","volume":"103","author":"Mustian","year":"2019","journal-title":"Transplantation"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.hpb.2016.01.546","article-title":"Health-related quality of life and affective status in liver transplant recipients and patients on the waiting list with low MELD scores.","volume":"18","author":"Benzing","year":"2016","journal-title":"HPB (Oxford)"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5455\/medarh.2016.70.48-52","article-title":"Prognostic significance of ascites and serum sodium in patients with low MELD scores.","volume":"70","author":"Prohic","year":"2016","journal-title":"Med Arch"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamasurg.2018.5568","article-title":"Assessment of trends in transplantation of liver grafts from older donors and outcomes in recipients of liver grafts from older donors, 2003-2016.","volume":"154","author":"Haugen","year":"2019","journal-title":"JAMA Surg"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/TP.0000000000002151","article-title":"Predicting liver allograft discard: the discard risk index.","volume":"102","author":"Rana","year":"2018","journal-title":"Transplantation"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/jamasurg.2020.2484","article-title":"Trends in outcomes for marginal allografts in liver transplant.","volume":"155","author":"Zhang","year":"2020","journal-title":"JAMA Surg"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00534-007-1300-z","article-title":"The use of marginal grafts in liver transplantation.","volume":"15","author":"Hashimoto","year":"2008","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R26-20250604","first-page":"555","article-title":"Donation after cardiac death as a strategy to increase deceased donor liver availability.","volume":"244","author":"Merion","year":"2006","journal-title":"Ann Surg"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00007890-199101000-00021","article-title":"The use of \u201cmarginal\u201d donors for organ transplantation. The influence of donor age on outcome.","volume":"51","author":"Alexander","year":"1991","journal-title":"Transplantation"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.gtc.2018.01.004","article-title":"Status of adult living donor liver transplantation in the United States: results from the adult-to-adult living donor liver transplantation cohort study.","volume":"47","author":"Abu-Gazala","year":"2018","journal-title":"Gastroenterol Clin North Am"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/SLA.0000000000003463","article-title":"Adult living donor versus deceased donor liver transplant (LDLT Versus DDLT) at a single center: time to change our paradigm for liver transplant.","volume":"270","author":"Humar","year":"2019","journal-title":"Ann Surg"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.3748\/wjg.v22.i18.4438","article-title":"Liver transplantation: current status and challenges.","volume":"22","author":"Jadlowiec","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jamasurg.2014.2038","article-title":"Survival benefit of solid-organ transplant in the United States.","volume":"150","author":"Rana","year":"2015","journal-title":"JAMA Surg"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1600-6143.2010.03127.x","article-title":"Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system.","volume":"10","author":"Washburn","year":"2010","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:21:21Z","timestamp":1749061281000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004345","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}